PubMed

Regulatory Landscape of Regenerative Dermatology: Current Frameworks and Future.

PMID: 41493254 · 2026-01-01

R, a, c, h, e, l, , L, , Z, i, e, b, a, r, t, ;, , B, a, r, b, a, r, a, , H, e, r, n, a, n, d, e, z, -, R, o, v, i, r, a, ;, , H, e, m, a, , S, u, n, d, a, r, a, m, ;, , S, a, m, a, n, t, h, a, , G, u, h, a, n, ;, , S, a, r, a, n, y, a, , P, , W, y, l, e, s

RevistaJournal of drugs in dermatology : JDD

Año2026-01-01

PMID41493254

Resumen

Regenerative dermatology is an emerging subspecialty that seeks to restore the structure and function of healthy skin. The United States lacks comprehensive regulatory guidance for regenerative therapies. This review provides an overview of available therapies within regenerative dermatology, outlining the pathways for approval. Articles on regenerative dermatology in PubMed and guidelines issued by the United States Food and Drug Administration (FDA) were reviewed with emphasis on those publish

Fuente oficial

Ver en PubMed →

Datos obtenidos de PubMed / NCBI. Para consultar el texto completo y la información más reciente, remítase siempre al registro oficial.